About us
- >
- About us >
- Information >
- Announcement
Announcement
-
2017-03-01Clinical trial ENERGI-F703 administered to the first patient
-
2017-02-01Clinical trial screening for the first patient for ENERGI-F703
-
0000-00-00The Australian patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
0000-00-00Announcement: Energenesis Biomedical's stock is going to be delisted from the emerging stock market, and will be transferring to the Taiwan Stock